TDP-43 SPECIFIC BINDING MOLECULES
Provided are novel TDP-43 -specific binding molecules including polypeptides such as human antibodies, as well as fragments, derivatives and variants thereof. Also provided are methods related to these TDP-43 specific binding molecules. Assays, kits, and solid supports related to TDP-43 -specific bi...
Saved in:
Main Authors | , , , , , |
---|---|
Format | Patent |
Language | English French |
Published |
06.03.2014
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Provided are novel TDP-43 -specific binding molecules including polypeptides such as human antibodies, as well as fragments, derivatives and variants thereof. Also provided are methods related to these TDP-43 specific binding molecules. Assays, kits, and solid supports related to TDP-43 -specific binding molecules, including polypeptides such as, human antibodies are also disclosed. The TDP-43-specific binding molecule, antibody, immunoglobulin chain(s), as well as binding fragments, derivatives and variants thereof can be used in pharmaceutical and diagnostic compositions for TDP-43 targeted immunotherapy and diagnosis, respectively.
L'invention concerne de nouvelles molécules de liaison spécifiques de TDP-43 incluant des polypeptides comme des anticorps humains, ainsi que des fragments, des dérivés et des variants de ceux-ci. L'invention concerne aussi des procédés liés à ces molécules de liaison spécifiques de TDP-43. Elle concerne aussi des tests, des trousses, et des supports solides apparentés aux molécules de liaison spécifiques de TDP-43, incluant des polypeptides comme, des anticorps humains. Les molécules de liaison spécifiques de TDP-43, les anticorps, la ou les chaînes d'immunoglobuline, ainsi que les fragments de liaison, les dérivés et les variants de ceux-ci peuvent être utilisés dans des compositions pharmaceutiques et de diagnostic pour l'immunothérapie ciblée de TDP-43 et le diagnostic, respectivement. |
---|---|
Bibliography: | Application Number: WO2012IB02905 |